BioNexus Gene Lab Balance Sheet (2018-2026)

Reported Financials

BioNexus Gene Lab Quarterly Balance Sheet

Periods 33 quarters

Latest Jun 2026

BioNexus Gene Lab reported total assets of $8.73M and total liabilities of $0.95M for the quarter ended Jun 2026, down 7.4% year over year. This balance sheet covers 33 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	1.70M	2.12M	1.84M	1.34M	1.46M	2.12M	1.97M	1.76M	6.15M	4.52M	5.83M	3.96M	2.67M	2.89M	2.09M	1.54M	1.36M	2.38M	2.40M	1.23M
Short-term InvestmentsInvestments (Current)	0.43M													2.79M		2.24M	1.74M	1.66M	2.63M	2.29M
Cash & Current Investments	2.13M	2.12M	1.84M	1.34M	1.46M	2.12M	1.97M	1.76M	6.15M	4.52M	5.83M	3.96M	2.67M	5.68M	2.09M	3.78M	3.10M	4.04M	5.03M	3.52M
Receivables - NetNet Receivables	4.19M	3.36M	3.03M	2.83M	2.73M	2.87M	2.53M	2.20M	0.90M	0.80M	0.84M	0.99M	1.43M	1.89M	1.44M	1.85M	1.52M	1.21M	0.96M	0.86M
Receivables - OtherOther Receivables	0.02M	0.78M	-0.33M	0.08M	0.07M	-0.10M	-0.34M	0.05M	0.11M	1.16M	0.11M	0.40M	0.07M	0.20M	0.24M	0.15M	0.10M	0.08M	0.09M	0.11M
Receivables	4.21M	4.13M	2.70M	2.91M	2.80M	2.77M	2.19M	2.24M	1.01M	1.96M	0.95M	1.39M	1.49M	2.10M	1.68M	2.00M	1.62M	1.29M	1.05M	0.97M
Work In Process														0.19M			0.19M
Inventory	1.49M	1.52M	1.65M	1.51M	1.10M	0.98M	0.90M	1.17M	1.11M	1.14M	1.08M	1.03M	1.39M	1.39M	1.18M	1.22M	1.01M	0.68M	0.67M	0.65M
Prepaid Assets																		0.08M	0.33M	0.58M
Current Assets	7.40M	7.15M	6.60M	5.77M	5.41M	6.02M	5.46M	5.23M	8.27M	8.05M	7.91M	7.84M	7.04M	7.43M	6.54M	6.38M	5.63M	5.45M	5.20M	4.94M
Non-Current Assets
Buildings													1.08M
Property, Plant & Equipment (Net)PP&E (Net)	1.65M	1.63M	1.63M	1.53M	1.44M	1.51M	1.48M	1.40M	1.50M	1.51M	1.47M	1.35M	1.73M	1.52M	1.52M	1.59M	1.57M	1.60M	1.58M	1.54M
Long-Term Investments	0.67M	0.75M	0.91M	1.04M	0.92M	1.15M	1.19M	1.23M	1.55M	1.70M	1.66M	1.71M	1.99M	1.27M	1.21M	1.25M	0.24M	2.03M	2.03M	2.03M
Intangibles														0.45M	0.45M
Goodwill & Intangibles														0.45M	0.45M
Long-Term Deferred Tax														9.40M				11.41M	12.16M	12.07M
Other Non-Current Assets	1.03M	1.55M	1.24M	0.85M	0.98M	1.51M	1.57M	1.46M	1.44M	3.31M	3.34M	3.21M	2.08M	1.49M	2.50M	1.52M	1.54M	1.55M	1.57M	1.13M
Non-Current Assets	2.36M	2.42M	2.57M	2.60M	2.39M	2.72M	2.73M	2.67M	3.20M	3.35M	3.26M	3.30M	3.96M	3.00M	2.94M	3.04M	1.99M	3.80M	3.84M	3.78M
Assets	9.77M	9.57M	9.18M	8.37M	7.80M	8.74M	8.19M	7.90M	11.47M	11.40M	11.16M	11.14M	11.00M	10.43M	9.48M	9.42M	7.62M	9.25M	9.04M	8.73M
Liabilities
Current Liabilities
Accounts Payables	2.41M	2.01M	1.83M	1.42M	1.28M	1.86M	1.49M	1.82M	1.57M	1.40M	1.43M	0.95M	1.03M	1.50M	1.18M	1.37M	0.18M	0.00M	0.00M	0.01M
Payables	2.41M	2.01M	1.83M	1.42M	1.28M	1.86M	1.49M	1.82M	1.57M	1.40M	1.43M	0.95M	1.03M	1.50M	1.18M	1.37M	0.18M	0.00M	0.00M	0.01M
Accumulated Expenses	0.07M	0.07M	0.04M	0.03M	0.04M	0.10M	0.04M	0.03M	0.03M	0.18M	0.21M	0.17M	0.29M	0.28M	0.29M	0.31M	0.38M	0.40M	0.59M	0.61M
Other Accumulated Expenses	0.02M	0.02M	0.02M	0.01M	0.01M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.06M	0.06M	0.06M	0.06M	0.06M
Current Leases	0.02M	0.02M	0.02M	0.01M	0.01M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.06M	0.06M	0.06M	0.06M	0.06M
Current Taxes	0.15M	0.10M	0.07M	0.04M					0.00M
Current Deferred Revenue		0.08M	107.00		0.01M	0.02M	0.02M	0.01M	0.01M			0.01M	0.02M	0.10M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M
Total Current Liabilities	2.66M	2.33M	1.98M	1.50M	1.33M	2.00M	1.56M	1.88M	1.64M	1.63M	1.72M	1.40M	1.41M	1.95M	1.56M	1.76M	0.68M	0.52M	0.80M	0.81M
Non-Current Liabilities
Capital Leases	0.02M	0.01M	0.01M																0.05M	0.05M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax	0.00M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.01M	0.01M	0.01M	0.01M
Operating Leases	0.03M	0.02M	0.02M	0.02M	0.01M	0.04M	0.04M	0.03M	0.10M	0.13M	0.09M	0.18M	0.18M	0.21M	0.20M	0.20M	0.18M	0.18M	0.16M	0.15M
Total Non-Current Liabilities	0.05M	0.07M	0.06M	0.04M	0.04M	0.07M	0.07M	0.06M	0.13M	0.11M	0.10M	0.19M	0.19M	0.16M	0.15M	0.14M	0.13M	0.12M	0.15M	0.14M
Total Liabilities	2.71M	2.39M	2.05M	1.55M	1.37M	2.08M	1.63M	1.94M	1.78M	1.74M	1.82M	1.59M	1.61M	2.11M	1.71M	1.90M	0.80M	0.64M	0.95M	0.95M
Shareholder's Equity
Common Equity	7.05M	7.18M	7.13M	6.82M	6.42M	6.67M	6.19M	5.59M	9.32M	9.66M	9.34M	9.55M	9.39M	8.32M	7.77M	7.52M	6.82M	8.61M	8.09M	7.78M
Liabilities and Shareholders Equity	9.77M	9.57M	9.18M	8.37M	7.80M	8.74M	8.19M	7.90M	11.47M	11.40M	11.16M	11.14M	11.00M	10.43M	9.48M	9.42M	7.62M	9.25M	9.04M	8.73M
Retained Earnings	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.01M	-5.39M	-6.43M	-6.97M	-7.26M
Preferred Shares		30.00M

BioNexus Gene Lab BGLC Balance Sheet (2018-2026)

BioNexus Gene Lab Quarterly Balance Sheet

Create an account

Sign In

Reset Password